Optimizing safety surveillance for COVID-19 vaccines
- PMID: 32555401
- PMCID: PMC7298922
- DOI: 10.1038/s41577-020-0372-8
Optimizing safety surveillance for COVID-19 vaccines
Abstract
Evolution of the current infrastructure for surveillance of vaccine safety will be essential to meet our commitments to the public in the deployment of a vaccine (or vaccines) to COVID-19. The incorporation of concepts and tools within the fields of data science and systems immunology can be used to propel vaccine safety monitoring into the twenty-first century.
Conflict of interest statement
The author declares no competing interests.
References
-
- Vaccine Confidence Project. State of vaccine confidence in the EU: 2018. Vaccine Confidencehttps://www.vaccineconfidence.org/research-feed/the-state-of-vaccine-con... (2018).
-
- World Health Organization. Ten threats to global health in 2019. WHOhttps://www.who.int/news-room/feature-stories/ten-threats-to-global-heal... (2019).
-
- European Medicines Agency. COVID-19: how EMA fast-tracks development support and approval of medicines and vaccines. EMAhttps://www.ema.europa.eu/en/news/covid-19-how-ema-fast-tracks-developme... (2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources